These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 11980256

  • 1. Drug use investigation (DUI) and prescription-event monitoring in Japan (J-PEM).
    Tanaka K, Morita Y, Kawabe E, Kubota K.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):653-8. PubMed ID: 11980256
    [Abstract] [Full Text] [Related]

  • 2. The ethical issues of the postmarketing surveillance of drug teratogenicity in Hungary.
    Czeizel AE.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):635-9. PubMed ID: 11980253
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ethical issues in a Brazilian hospital.
    de Castro MS, Goldim JR, Ferreira MB.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):601-5. PubMed ID: 11980247
    [Abstract] [Full Text] [Related]

  • 5. Privacy issues and the monitoring of sumatriptan in the New Zealand Intensive Medicines Monitoring Programme.
    Coulter DM.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):663-7. PubMed ID: 11980258
    [Abstract] [Full Text] [Related]

  • 6. Ethical issues related to retrospective drug utilization studies in South Africa.
    Truter I.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):679-83. PubMed ID: 11980261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ethical challenges in pharmacoepidemiological research in Colombia.
    Dennis RJ, Lozano JM.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):613-8. PubMed ID: 11980249
    [Abstract] [Full Text] [Related]

  • 9. A pilot study to build a database on seven anti-hypertensive drugs.
    Fujita T, Miura Y, Mayama T.
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):41-6. PubMed ID: 15534857
    [Abstract] [Full Text] [Related]

  • 10. Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research.
    Parkin L, Paul C.
    J Epidemiol Community Health; 2011 Feb; 65(2):150-6. PubMed ID: 19948532
    [Abstract] [Full Text] [Related]

  • 11. Data safety and drug safety in Germany: a closing gap?
    Rathmann W.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):625-30. PubMed ID: 11980251
    [Abstract] [Full Text] [Related]

  • 12. Systemic conditions for performance of pharmacoepidemiologic studies in Slovenia.
    Primozic S, Kos M, Mrhar A, Ravnik I.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):675-8. PubMed ID: 11980260
    [Abstract] [Full Text] [Related]

  • 13. Ethical issues in pharmacoepidemiological research in Belgium.
    Verstraete AG, Vander Stichele RH, Deliens LH.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):595-9. PubMed ID: 11980246
    [Abstract] [Full Text] [Related]

  • 14. Ethical issues arising in pharmacoepidemiologic research in a community hospital in Crete, Greece.
    Tzimis L.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):631-3. PubMed ID: 11980252
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
    Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW.
    Arch Intern Med; 2007 May 28; 167(10):1041-9. PubMed ID: 17533207
    [Abstract] [Full Text] [Related]

  • 16. Research methods in drug surveillance.
    Engel RR, Grohmann R, Rüther E, Hippius H.
    Pharmacopsychiatry; 2004 Mar 28; 37 Suppl 1():S12-5. PubMed ID: 15052510
    [Abstract] [Full Text] [Related]

  • 17. [Reform of Japan's NTP and its technical perspectives].
    Mori T.
    Kekkaku; 2004 Oct 28; 79(10):587-604. PubMed ID: 15631111
    [Abstract] [Full Text] [Related]

  • 18. Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data.
    Rawson NS.
    Pharmacoepidemiol Drug Saf; 2001 Dec 28; 10(7):607-12. PubMed ID: 11980248
    [Abstract] [Full Text] [Related]

  • 19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology.
    J Clin Oncol; 2003 Jun 15; 21(12):2397-406. PubMed ID: 12692171
    [Abstract] [Full Text] [Related]

  • 20. Privacy considerations in the context of an Australian observational database.
    Duszynski KM, Beilby JJ, Marley JE, Walker DC, Pratt NL.
    Pharmacoepidemiol Drug Saf; 2001 Dec 15; 10(7):587-94. PubMed ID: 11980245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.